Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04544995
Title Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Pediatric Participants With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

neuroblastoma

osteosarcoma

Ewing sarcoma

Advanced Solid Tumor

adrenocortical carcinoma

rhabdomyosarcoma

Therapies

Dostarlimab-gxly + Niraparib

Age Groups: child
Covered Countries FRA | ESP

Facility Status City State Zip Country Details
GSK Investigational Site Recruiting Lille 59000 France Details
GSK Investigational Site Recruiting Lyon 69008 France Details
GSK Investigational Site Recruiting Marseille 13005 France Details
GSK Investigational Site Recruiting Paris cedex 05 75248 France Details
GSK Investigational Site Recruiting Paris 75012 France Details
GSK Investigational Site Recruiting Villejuif 94805 France Details
GSK Investigational Site Recruiting Barcelona 08035 Spain Details
GSK Investigational Site Recruiting Esplugues De Llobregat. Barcelona 08950 Spain Details
GSK Investigational Site Recruiting Madrid 28009 Spain Details
GSK Investigational Site Recruiting Madrid 28046 Spain Details
GSK Investigational Site Recruiting Valencia 46026 Spain Details
GSK Investigational Site Recruiting Glasgow G51 4TF United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field